SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-014469
Filing Date
2021-11-04
Accepted
2021-11-04 08:59:41
Documents
60
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q albo-20210930x10q.htm   iXBRL 10-Q 1744054
2 EX-10.1 albo-20210930xex10d1.htm EX-10.1 311480
3 EX-10.2 albo-20210930xex10d2.htm EX-10.2 28725
4 EX-31.1 albo-20210930xex31d1.htm EX-31.1 10378
5 EX-31.2 albo-20210930xex31d2.htm EX-31.2 10343
6 EX-32.1 albo-20210930xex32d1.htm EX-32.1 10548
  Complete submission text file 0001558370-21-014469.txt   5776866

Data Files

Seq Description Document Type Size
7 EX-101.SCH albo-20210930.xsd EX-101.SCH 37316
8 EX-101.CAL albo-20210930_cal.xml EX-101.CAL 41508
9 EX-101.DEF albo-20210930_def.xml EX-101.DEF 143644
10 EX-101.LAB albo-20210930_lab.xml EX-101.LAB 326788
11 EX-101.PRE albo-20210930_pre.xml EX-101.PRE 239079
12 EXTRACTED XBRL INSTANCE DOCUMENT albo-20210930x10q_htm.xml XML 692760
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 211378398
SIC: 2834 Pharmaceutical Preparations